Document is current
Any future updates will be listed below
-
Authors
Jaroentomeechai, Thapakorn
Karlsson, Richard
Goerdeler, Felix https://orcid.org/0000-0002-7190-9145
Teoh, Fallen Kai Yik
Grønset, Magnus Nørregaard
de Wit, Dylan
Chen, Yen-Hsi https://orcid.org/0000-0001-9484-3145
Furukawa, Sanae
Psomiadou, Venetia
Hurtado-Guerrero, Ramon https://orcid.org/0000-0002-3122-9401
Vidal-Calvo, Elena Ethel https://orcid.org/0000-0001-9655-2106
Salanti, Ali https://orcid.org/0000-0003-2207-5575
Boltje, Thomas J.
van den Bos, Leendert J.
Wunder, Christian https://orcid.org/0000-0001-9091-0080
Johannes, Ludger https://orcid.org/0000-0002-2168-0004
Schjoldager, Katrine T. https://orcid.org/0000-0002-8592-6763
Joshi, Hiren J. https://orcid.org/0000-0002-8192-2829
Miller, Rebecca L. https://orcid.org/0000-0001-8574-1948
Clausen, Henrik https://orcid.org/0000-0002-0915-5055
Vakhrushev, Sergey Y. https://orcid.org/0000-0002-0418-5765
Narimatsu, Yoshiki https://orcid.org/0000-0003-1428-5695
- License Information
-
More Information
Article History
Received: 23 August 2024
Accepted: 22 October 2024
First Online: 8 November 2024
Competing interests
: Y.N., Y.H.C., and H.C. have a financial interest in GlycoDisplay Aps, Y.N., Y.H.C., and H.C.’s interests are reviewed and managed by the University of Copenhagen in accordance with their conflict of interest policies. L.J.v.d.B. has a financial interest in EnzyTag BV. A.S. and E.E.V-C. have a financial interest in VAR2Pharmaceuticals. A.S. has financial interest in VARCT Diagnostics. All other authors declare no competing interests.
